• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光化性角化病:全面更新

Actinic keratoses: a comprehensive update.

作者信息

Ibrahim Sherrif F, Brown Marc D

机构信息

University of Rochester School of Medicine and Dentistry, Department of Dermatology, Rochester, New York.

出版信息

J Clin Aesthet Dermatol. 2009 Jul;2(7):43-8.

PMID:20729970
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2924136/
Abstract

Actinic keratoses are common intra-epidermal neoplasms that lie on a continuum with squamous cell carcinoma. Tightly linked to ultraviolet irradiation, they occur in areas of chronic sun exposure, and early treatment of these lesions may prevent their progression to invasive disease. A large variety of effective treatment modalities exist, and the optimal therapeutic choice is dependent on a variety of patient- and physician-associated variables. Many established and more recent approaches are discussed in this review with a focus on efficacy and administration techniques. Several previously experimental options, such as imiquimod and photodynamic therapy, have become incorporated as first-line options for the treatment of actinic keratoses, while combination treatment strategies have been gaining in popularity. The goal of all therapies is to ultimately limit the morbidity and mortality of squamous cell carcinoma. (J Clin Aesthetic Dermatol. 2009;2(7):43-48.).

摘要

光化性角化病是常见的表皮内肿瘤,与鳞状细胞癌处于连续谱中。它们与紫外线照射密切相关,发生于慢性阳光暴露部位,早期治疗这些病变可预防其进展为侵袭性疾病。存在多种有效的治疗方式,最佳治疗选择取决于多种患者和医生相关变量。本综述讨论了许多已确立的和最新的方法,重点是疗效和给药技术。几种先前的实验性选择,如咪喹莫特和光动力疗法,已成为治疗光化性角化病的一线选择,而联合治疗策略也越来越受欢迎。所有治疗的目标最终都是限制鳞状细胞癌的发病率和死亡率。(《临床美容皮肤病学杂志》。2009年;2(7):43 - 48。)

相似文献

1
Actinic keratoses: a comprehensive update.光化性角化病:全面更新
J Clin Aesthet Dermatol. 2009 Jul;2(7):43-8.
2
Actinic keratosis. Current treatment options.光化性角化病。当前的治疗选择。
Am J Clin Dermatol. 2000 May-Jun;1(3):167-79. doi: 10.2165/00128071-200001030-00004.
3
Treatment options for actinic keratoses.光化性角化病的治疗选择。
Am Fam Physician. 2007 Sep 1;76(5):667-71.
4
The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer.晒伤疼痛和终生阳光暴露对光化性角化病、脂溢性疣、黑素细胞痣、非典型痣及皮肤癌风险的影响。
J Invest Dermatol. 2003 Jun;120(6):1087-93. doi: 10.1046/j.1523-1747.2003.12246.x.
5
Imiquimod 3.75% cream (Zyclara) for the treatment of actinic keratoses.咪喹莫特 3.75% 乳膏(泽珂乐)治疗光化性角化病。
Expert Opin Pharmacother. 2011 Feb;12(3):451-61. doi: 10.1517/14656566.2011.549128.
6
A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients.一项关于外用氨基乙酰丙酸光动力疗法治疗移植受者光化性角化病的随机对照临床试验。
Br J Dermatol. 2004 Jul;151(1):196-200. doi: 10.1111/j.1365-2133.2004.06054.x.
7
The treatment of actinic keratoses.光化性角化病的治疗
J Am Acad Dermatol. 2000 Jan;42(1 Pt 2):25-8. doi: 10.1067/mjd.2000.103338.
8
Cryopeeling (extensive cryosurgery) for treatment of actinic keratoses: an update and comparison.用于治疗光化性角化病的冷冻剥脱术(广泛冷冻手术):最新进展与比较
Dermatol Surg. 2000 Aug;26(8):728-32. doi: 10.1046/j.1524-4725.2000.99197.x.
9
Therapeutic strategies for actinic keratoses--a systematic review.光化性角化病的治疗策略——系统评价。
Eur J Dermatol. 2013 Jan-Feb;23(1):14-32. doi: 10.1684/ejd.2013.1923.
10
[Actinic keratoses].[光化性角化病]
Hautarzt. 2003 Jun;54(6):551-60; quiz 561-2. doi: 10.1007/s00105-003-0543-0.

引用本文的文献

1
Safety and tolerability of tirbanibulin ointment 1% treatment on 100 cm of the face or scalp in patients with actinic keratosis: A phase 3 study.1%替巴尼布林软膏治疗光化性角化病患者面部或头皮100平方厘米区域的安全性和耐受性:一项3期研究。
JAAD Int. 2024 Jul 18;17:6-14. doi: 10.1016/j.jdin.2024.07.001. eCollection 2024 Dec.
2
Evaluating the Noninferiority of a New Photodynamic Therapy (Flexitheralight) Compared With Conventional Treatment for Actinic Keratosis: Protocol for a Phase 2 Study.评估一种新型光动力疗法(Flexitheralight)与传统治疗方法相比治疗光化性角化病的非劣效性:一项2期研究方案。
JMIR Res Protoc. 2019 Apr 26;8(4):e11530. doi: 10.2196/11530.
3
Ingenol Mebutate Topical Gel A Status Report On Clinical Use Beyond Actinic Keratosis.ingenol mebutate外用凝胶:光化性角化病以外临床应用的现状报告
J Clin Aesthet Dermatol. 2016 Nov;9(11 Suppl 1):S3-S11.
4
Histopathological analysis of the therapeutic response to cryotherapy with liquid nitrogen in patients with multiple actinic keratosis.液氮冷冻疗法治疗多发性光化性角化病患者疗效的组织病理学分析
An Bras Dermatol. 2015 May-Jun;90(3):384-9. doi: 10.1590/abd1806-4841.20153302. Epub 2015 Jun 1.
5
Comprehensive management of actinic keratoses: practical integration of available therapies with a review of a newer treatment approach.光化性角化病的综合管理:现有治疗方法的实际整合及一种新治疗方法的综述
J Clin Aesthet Dermatol. 2014 Sep;7(9 Suppl S2-S12):S2-S12.
6
Interventions for actinic keratoses.光化性角化病的干预措施。
Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD004415. doi: 10.1002/14651858.CD004415.pub2.

本文引用的文献

1
Placebo-controlled, double-blind, randomized pilot study of imiquimod 5% cream applied once per week for 6 months for the treatment of actinic keratoses.一项安慰剂对照、双盲、随机的试点研究,使用5%咪喹莫特乳膏每周一次,持续6个月治疗光化性角化病。
J Am Acad Dermatol. 2009 Jan;60(1):59-62. doi: 10.1016/j.jaad.2008.08.039. Epub 2008 Oct 19.
2
Diclofenac sodium 3% gel in the treatment of actinic keratoses postcryosurgery.3%双氯芬酸钠凝胶用于治疗冷冻治疗后的光化性角化病。
J Drugs Dermatol. 2008 Jul;7(7):669-73.
3
Open-label study to assess the safety and efficacy of imiquimod 5% cream applied once daily three times per week in cycles for treatment of actinic keratoses on the head.一项开放标签研究,旨在评估5%咪喹莫特乳膏每周三次、每日一次循环给药治疗头部光化性角化病的安全性和有效性。
J Cutan Med Surg. 2008 May-Jun;12(3):97-101. doi: 10.2310/7750.2008.07045.
4
A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up.对免疫功能正常的光化性角化病患者进行的一项随机研究:比较外用5%咪喹莫特、外用5-氟尿嘧啶与冷冻手术,包括1年随访的临床和组织学结果对比
Br J Dermatol. 2007 Dec;157 Suppl 2:34-40. doi: 10.1111/j.1365-2133.2007.08271.x.
5
Long-term efficacy of carbon dioxide laser resurfacing for facial actinic keratosis.二氧化碳激光换肤治疗面部光化性角化病的长期疗效。
J Oral Maxillofac Surg. 2007 Jun;65(6):1135-9. doi: 10.1016/j.joms.2006.10.023.
6
Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005.非黑色素瘤皮肤癌光动力治疗应用指南:国际共识。国际皮肤光动力治疗学会,2005年。
J Am Acad Dermatol. 2007 Jan;56(1):125-43. doi: 10.1016/j.jaad.2006.06.006.
7
Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study.光化性角化病患者局部应用氨基乙酰丙酸光动力疗法与冷冻疗法的个体内左右对比:一项多中心随机对照研究
Br J Dermatol. 2006 Nov;155(5):1029-36. doi: 10.1111/j.1365-2133.2006.07470.x.
8
Actinic keratoses and the incidence of occult squamous cell carcinoma: a clinical-histopathologic correlation.光化性角化病与隐匿性鳞状细胞癌的发病率:临床-组织病理学相关性
Dermatol Surg. 2006 Oct;32(10):1261-5. doi: 10.1111/j.1524-4725.2006.32287.x.
9
Frequency and cost of actinic keratosis treatment.光化性角化病治疗的频率和成本。
Dermatol Surg. 2006 Aug;32(8):1045-9. doi: 10.1111/j.1524-4725.2006.32228.x.
10
A clinical comparison and long-term follow-up of topical 5-fluorouracil versus laser resurfacing in the treatment of widespread actinic keratoses.
Lasers Surg Med. 2006 Sep;38(8):731-9. doi: 10.1002/lsm.20379.